UniSuper Management Pty Ltd increased its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 57.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 195,848 shares of the industrial products company’s stock after purchasing an additional 71,472 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Xylem were worth $26,671,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. Knuff & Co LLC purchased a new position in Xylem in the 3rd quarter worth $27,000. Board of the Pension Protection Fund purchased a new position in Xylem in the 4th quarter worth $27,000. Commonwealth Retirement Investments LLC purchased a new position in Xylem in the 4th quarter worth $27,000. Wexford Capital LP purchased a new position in Xylem in the 3rd quarter worth $27,000. Finally, Ramirez Asset Management Inc. raised its position in Xylem by 100.0% in the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Price Performance
Shares of Xylem stock opened at $108.97 on Friday. The firm has a market cap of $25.90 billion, a PE ratio of 27.11, a price-to-earnings-growth ratio of 1.52 and a beta of 1.04. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The company’s fifty day simple moving average is $116.03 and its two-hundred day simple moving average is $127.48.
Xylem announced that its Board of Directors has approved a stock buyback program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date is Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem’s dividend payout ratio (DPR) is 42.79%.
Insider Activity
In related news, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.32% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts recently commented on XYL shares. Oppenheimer decreased their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price target (down from $140.00) on shares of Xylem in a report on Tuesday, March 31st. UBS Group raised their price target on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. TD Cowen reissued a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Finally, Stifel Nicolaus cut their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.
View Our Latest Analysis on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Further Reading
- Five stocks we like better than Xylem
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
